CAMBRIDGE, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic ...
Zacks Investment Research on MSN
Why is Black Diamond (BDTX) up 19.3% since last earnings report?
A month has gone by since the last earnings report for Black Diamond (BDTX). Shares have added about 19.3% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results